Your browser doesn't support javascript.
loading
Prevalence of Visual Acuity Loss or Blindness in the US: A Bayesian Meta-analysis.
Flaxman, Abraham D; Wittenborn, John S; Robalik, Toshana; Gulia, Rohit; Gerzoff, Robert B; Lundeen, Elizabeth A; Saaddine, Jinan; Rein, David B.
Afiliação
  • Flaxman AD; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Wittenborn JS; NORC at the University of Chicago, Chicago, Illinois.
  • Robalik T; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Gulia R; Institute for Health Metrics and Evaluation, University of Washington, Seattle.
  • Gerzoff RB; Applied Statistical Consulting LLC, Atlanta, Georgia.
  • Lundeen EA; Division of Diabetes Translation, Vision Health Initiative Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Saaddine J; Division of Diabetes Translation, Vision Health Initiative Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Rein DB; NORC at the University of Chicago, Chicago, Illinois.
JAMA Ophthalmol ; 139(7): 717-723, 2021 Jul 01.
Article em En | MEDLINE | ID: mdl-33983373
ABSTRACT
IMPORTANCE Globally, more than 250 million people live with visual acuity loss or blindness, and people in the US fear losing vision more than memory, hearing, or speech. But it appears there are no recent empirical estimates of visual acuity loss or blindness for the US.

OBJECTIVE:

To produce estimates of visual acuity loss and blindness by age, sex, race/ethnicity, and US state. DATA SOURCES Data from the American Community Survey (2017), National Health and Nutrition Examination Survey (1999-2008), and National Survey of Children's Health (2017), as well as population-based studies (2000-2013), were included. STUDY SELECTION All relevant data from the US Centers for Disease Control and Prevention's Vision and Eye Health Surveillance System were included. DATA EXTRACTION AND

SYNTHESIS:

The prevalence of visual acuity loss or blindness was estimated, stratified when possible by factors including US state, age group, sex, race/ethnicity, and community-dwelling or group-quarters status. Data analysis occurred from March 2018 to March 2020. MAIN OUTCOMES OR

MEASURES:

The prevalence of visual acuity loss (defined as a best-corrected visual acuity greater than or equal to 0.3 logMAR) and blindness (defined as a logMAR of 1.0 or greater) in the better-seeing eye.

RESULTS:

For 2017, this meta-analysis generated an estimated US prevalence of 7.08 (95% uncertainty interval, 6.32-7.89) million people living with visual acuity loss, of whom 1.08 (95% uncertainty interval, 0.82-1.30) million people were living with blindness. Of this, 1.62 (95% uncertainty interval, 1.32-1.92) million persons with visual acuity loss are younger than 40 years, and 141 000 (95% uncertainty interval, 95 000-187 000) persons with blindness are younger than 40 years. CONCLUSIONS AND RELEVANCE This analysis of all available data with modern methods produced estimates substantially higher than those previously published.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Baixa Visão / Pessoas com Deficiência Visual Tipo de estudo: Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Baixa Visão / Pessoas com Deficiência Visual Tipo de estudo: Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article